WebOfPharma · Process Validation and PPQ

PPQ Report: Format, Requirements and Example

A practical guide to turning process performance qualification data into a clear, traceable, and inspection-ready pharmaceutical validation decision.

Stage 2 process qualification Data analysis Deviation assessment Quality approval

PPQ Report: Format, Requirements and Example

Quick answer

A PPQ report is the final evidence-based document that compares planned protocol requirements with actual execution, summarizes process and product data, evaluates deviations and unexpected observations, and states whether the commercial process demonstrated reproducible performance. A strong report includes batch and material details, sampling and statistics, predefined acceptance criteria, data-integrity review, limitations, actions, conclusion, and approvals. It should be written promptly after execution and should not hide nonconforming or excluded data.

Purpose

What does the report decide?

Whether the executed PPQ study demonstrates a reproducible commercial process under approved conditions.

Evidence

What must be summarized?

Batch records, materials, CPPs, CQAs, samples, results, statistics, deviations, and data-integrity checks.

Decision

What is the conclusion?

Pass, conditional acceptance, additional work required, or failure—always supported by documented rationale.

Lifecycle

What follows approval?

Continued process verification, monitoring, change control, CAPA, and periodic review of the validated state.

What Is a PPQ Report?

A PPQ report is the controlled summary and conclusion of a Process Performance Qualification study. It documents what was planned, what actually happened, what the data show, and whether the process is ready for routine commercial manufacture.

PPQ is the second element of Stage 2 process qualification. It combines qualified facilities, utilities, equipment, trained personnel, approved procedures, components, and the commercial manufacturing process to produce representative commercial-scale batches. The report converts that execution into a decision that can be reviewed by Production, Engineering, Quality Control, Quality Assurance, Regulatory Affairs, and the Qualified Person where applicable.

The report is not a replacement for the approved PPQ protocol. The protocol defines the plan and acceptance criteria; the report demonstrates execution against that plan and explains any difference between the planned and actual study.

Regulatory framing: FDA process-validation guidance describes PPQ as part of Stage 2 and recommends a timely report that cross-references the protocol, summarizes and analyzes data, evaluates unexpected observations and nonconformances, describes corrective actions or control changes, gives a clear state-of-control conclusion, and includes Quality and departmental approvals.

PPQ Protocol Versus PPQ Report

Confusing the protocol with the report is a common documentation weakness. The two documents are linked, but they serve different purposes.

Document	Primary question	Typical content
PPQ protocol	What will be done and what will count as acceptable?	Objective, scope, batch plan, process conditions, sampling, tests, acceptance criteria, statistics, responsibilities, deviations, and approvals before execution.
PPQ report	What was done, what did the data show, and what should be decided?	Execution summary, actual conditions, results, statistics, deviations, investigations, limitations, conclusion, actions, and approvals after execution.
CPV report	Does routine production remain in a state of control?	Ongoing product/process trends, control charts, capability, alerts, investigations, and lifecycle monitoring after PPQ.

Keep the approved protocol, executed records, laboratory data, investigations, and final report cross-referenced so an auditor can move from a conclusion back to the original evidence without relying on informal explanations.

Regulatory Expectations for a PPQ Report

There is no single universal report template that fits every product or process. The report should be proportionate to risk and detailed enough to show that the commercial process can consistently deliver product meeting predetermined quality attributes.

Expectation	How it appears in the report
Approved plan	Protocol number, version, approval date, scope, and evidence that Quality approved execution before the first PPQ batch.
Representative commercial execution	Batch size, facility, equipment, materials, personnel, operating conditions, and routine procedures are identified and justified.
Predefined criteria	Each CQA, CPP, in-process check, yield, sampling test, and statistical criterion is compared with the approved acceptance criterion.
Complete data review	Results, trends, variability, outliers, rejected tests, repeat tests, missing data, and unexpected observations are addressed.
Nonconformance assessment	Deviations, atypical results, OOS/OOT events, alarms, interventions, and equipment issues are investigated for impact on validity.
Clear decision	The report states whether the process met the protocol and is in a state of control, or what must happen before that conclusion is reached.
Quality approval	Responsible departments and the Quality Unit approve the report and any conditions, restrictions, actions, or follow-up monitoring.

FDA guidance is nonbinding guidance, while applicable GMP statutes and regulations remain enforceable. Align the report with your approved cGMP procedures, marketing authorization, and site validation policy.

PPQ Report Format: Recommended Sections

A consistent format makes review faster and prevents important evidence from being buried in attachments. The following structure can be adapted to tablets, capsules, liquids, sterile products, biologics, APIs, and combination processes.

Section	What to include	Reviewer question
1. Document control	Title, product, strength, site, protocol/report numbers, versions, effective date, authors, reviewers, and approvers.	Can the report be uniquely identified and linked to the approved study?
2. Executive summary	Scope, batches, overall result, major deviations, limitations, conclusion, actions, and release or CPV recommendation.	Can a decision maker understand the outcome without losing the key caveats?
3. Objective and scope	Process, dosage form, site, equipment train, strengths, batch size, unit operations, and exclusions.	Does the executed study match the intended commercial process?
4. Protocol and change history	Approved protocol, amendments, pre-approved changes, and rationale for any change.	Were deviations from the plan controlled and authorized?
5. Batch and material details	Batch numbers, dates, sizes, raw-material lots, packaging, equipment, utilities, operators, and environmental conditions.	Are the PPQ batches representative and traceable?
6. Manufacturing execution	Actual parameters, interventions, holds, stoppages, alarms, start-up, shutdown, and operating ranges.	Was the process run under normal and expected conditions?
7. Sampling and testing	Sampling points, quantities, timing, methods, laboratories, sample identity, testing status, and data review.	Do samples represent within-batch and between-batch performance?
8. Results and statistics	CQA/CPP tables, trends, variability, capability where meaningful, outlier review, and comparison with criteria.	Does the evidence support reproducibility and control?
9. Deviations and investigations	Deviation IDs, description, root cause, impact assessment, invalidated data rationale, CAPA, and closure status.	Could any event change the validity or interpretation of the study?
10. Data-integrity review	Record completeness, audit trails, calculations, repeat tests, sample reconciliation, electronic data, and ALCOA+ checks.	Can the reported conclusion be reconstructed from original data?
11. Discussion and limitations	Unexpected results, exclusions, assumptions, batch differences, statistical limitations, and residual risks.	Does the report communicate uncertainty honestly?
12. Conclusion and recommendation	Meets/does not meet criteria, state-of-control decision, restrictions, additional PPQ, CPV, requalification, or change-control actions.	Is the final decision unambiguous and scientifically justified?
13. Approvals	Production, Engineering, QC, QA, Validation, Regulatory, and Qualified Person approvals as applicable.	Did accountable functions approve the outcome?
14. Attachments	Executed batch records, raw data, certificates, charts, trend files, deviations, investigations, protocols, and calculations.	Can every major statement be traced to evidence?

PPQ Report Preparation Workflow

Prepare the report as an evidence review, not as a last-minute narrative. A controlled workflow reduces rework and reveals missing data while the batch team still remembers what happened.

Freeze the study scopeConfirm the approved protocol, batch list, protocol amendments, acceptance criteria, and report owner.

Reconcile execution recordsCompare batch records, equipment logs, material records, environmental records, samples, and laboratory status.

Build the data setCollect raw and summarized results with batch, time, location, method, analyst, instrument, and sample identifiers.

Review criteria and statisticsCompare every result with predefined criteria and calculate the planned within-batch and between-batch metrics.

Resolve exceptionsLink deviations, atypical results, OOS/OOT investigations, repeat tests, alarms, and CAPA to the affected data.

Draft conclusionState whether the process met the protocol and whether evidence supports a state-of-control decision.

Cross-functional reviewRoute the report to Production, Engineering, QC, QA, Validation, Regulatory, and other accountable owners.

Approve and transitionClose or transfer actions, define CPV monitoring, file the package, and communicate restrictions or follow-up.

Executive Summary: What Good Looks Like

The executive summary should be short enough for management review but complete enough to prevent an overly positive reading of the data. Include the following points:

Product, strength, dosage form, site, process, and approved protocol number.
Number, size, and identifiers of PPQ batches evaluated.
Overall result for CQAs, CPPs, yield, in-process controls, and release testing.
Major deviations, investigations, atypical results, and unresolved actions.
Statement about batch representativeness and execution under routine conditions.
Statistical summary of within-batch and between-batch variability.
Decision: successful, conditionally acceptable, additional work required, or unsuccessful.
CPV, CAPA, change-control, monitoring, or requalification commitments.

Example wording: “Three commercial-scale batches were manufactured under the approved PPQ protocol using qualified equipment, approved materials, trained personnel, and routine procedures. All predefined CQA and CPP criteria were met. One minor deviation was investigated and determined not to affect product quality or study validity. The data support a conclusion that the process is in a state of control, subject to the enhanced CPV plan listed in Section 12.”

Batch Representativeness and Execution Review

A report should explain why the batches are representative of commercial manufacture. “Three batches passed” is not enough if the batches used unusual operators, materials, equipment, or temporary controls.

Representativeness factor	Report evidence	Potential limitation
Batch size and scale	Actual size compared with intended commercial size and approved range.	Engineering or demonstration scale may not represent commercial mixing, heat transfer, or residence time.
Materials	Supplier, grade, lot, incoming status, attributes, and quantities.	Development lots or atypical material properties may restrict generalization.
Equipment and utilities	Equipment IDs, qualification status, calibration, utilities, and operating ranges.	Temporary equipment, bypasses, or unqualified support systems require impact assessment.
Personnel and procedures	Trained routine operators, approved master records, SOPs, and normal shift coverage.	Specialist support or non-routine intervention may limit routine-use conclusions.
Environment and conditions	Temperature, humidity, cleanroom status, water, HVAC, and other relevant conditions.	Seasonal or environmental variation may need additional monitoring.

PPQ Data Analysis and Statistics

The report should use the methods stated in the approved protocol. Select statistics that answer the process question; do not add impressive metrics after seeing the results without explaining the change.

Common analysis areas

Within-batch variability: compare locations, times, samples, or units across a batch.
Between-batch variability: compare batch means, ranges, standard deviations, and trends.
Process performance: use capability or performance metrics only when assumptions, limits, distribution, and sample size are appropriate.
Trend and shift review: examine run charts, control charts, moving ranges, and time-order patterns.
Outlier assessment: investigate unusual values scientifically; never delete data simply because it weakens the conclusion.
Multivariate evidence: evaluate relationships between CPPs and CQAs when the process knowledge supports that analysis.

Illustrative process capability: Cp = (USL − LSL) / (6σ); Cpk = minimum[(USL − μ)/(3σ), (μ − LSL)/(3σ)]. Use only with justified assumptions and protocol-defined interpretation.

Use capability metrics only when the process is stable enough, the specification limits are meaningful, the sample size is adequate, and the distributional assumptions or non-parametric alternatives are justified.

Sample PPQ Results Table

The following table is an illustrative format. Values and limits must be replaced with approved, product-specific criteria before use.

Attribute or parameter	Acceptance criterion	Batch PPQ-001	Batch PPQ-002	Batch PPQ-003	Conclusion
Assay	98.0–102.0%	99.3%	99.7%	99.5%	Pass
Content uniformity AV	AV ≤ 15.0	7.8	8.6	6.9	Pass
Dissolution at 30 min	NLT 80%	88%	87%	89%	Pass
Blend uniformity RSD	≤ 5.0%	2.1%	2.6%	2.3%	Pass
Compression force	Approved operating range	Within range	Within range	Within range	Pass
Yield	95.0–102.0%	98.8%	99.1%	98.7%	Pass
Deviation DV-024	Investigate impact	Temperature probe alarm for 3 minutes during controlled hold; no product impact demonstrated.			Accepted with action

The narrative should explain the calculation basis, sample locations, result reconciliation, laboratory method status, and why the deviation does or does not affect the conclusion.

Deviation, OOS, OOT, and Nonconformance Assessment

Every deviation or unexpected observation should be assessed for its effect on product quality, process performance, data integrity, batch representativeness, and PPQ validity. A deviation does not automatically fail the PPQ, but a report cannot declare success while leaving its impact unexplained.

Assessment question	Evidence to describe
What happened?	Event time, unit operation, equipment, batch, operator, alarm, record, and immediate action.
Was the protocol or approved procedure affected?	Exact section, step, limit, sample, parameter, or record affected.
Was product quality affected?	Scientific impact assessment using process knowledge, additional data, testing, and material disposition.
Was data integrity affected?	Original records, audit trails, missing data, repeat testing, calculations, and sample reconciliation.
Does the event affect representativeness?	Whether the batch remains a valid example of routine commercial processing.
What action is required?	Correction, CAPA, change control, additional monitoring, requalification, additional PPQ, or no further action with rationale.

Do not exclude inconvenient data: Repeated tests, aborted runs, atypical results, and failed samples should be addressed using approved procedures. Exclusion requires a scientifically justified, documented reason—not the fact that the result weakens the PPQ conclusion.

Link quality-system actions to CAPA or your approved CAPA new workflow when systemic causes or recurring risks are identified.

Data Integrity Review in a PPQ Report

Data integrity review should confirm that the report is built from complete and traceable evidence. The review should cover both paper and electronic records, including raw data and metadata that support the reported results.

All batch records, logbooks, worksheets, and electronic data are accounted for.
Sample identities, collection times, locations, quantities, and test status reconcile.
Calculations are formula-controlled, independently checked, and traceable to source data.
Repeat tests, reinjections, reprocessing, invalidated results, and OOS/OOT events are included.
Audit trails and electronic signatures are reviewed for critical data and approvals.
Changes, corrections, transcriptions, and late entries follow approved procedures.
Attachments, chromatograms, instrument files, trend charts, and certificates are linked.
Record retention, readability, and retrieval are confirmed for the approved package.

Use ALCOA+ principles as a practical lens for evaluating whether PPQ evidence remains attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available.

Worked Example: Oral Solid Dosage PPQ Report

This example demonstrates how a report can turn a result set into a controlled decision. It is not a universal acceptance standard.

Study context

Product: Immediate-release tablet, 500 mg strength.
Process: Dispensing, blending, wet granulation, drying, milling, lubrication, compression, and coating.
Batches: Three commercial-scale batches manufactured on the qualified production line.
Primary CQAs: Assay, content uniformity, dissolution, friability, hardness, and appearance.
Key CPPs: Granulation endpoint, inlet temperature, drying endpoint, lubrication time, compression force, and coating spray rate.

Decision summary

Decision element	Report conclusion
Execution	All three batches followed approved master records with trained routine operators. Equipment and utilities were qualified and within calibration.
Critical process parameters	All CPPs remained within approved ranges. Granulation endpoint and drying endpoint showed low batch-to-batch variability.
Critical quality attributes	Assay, content uniformity, dissolution, friability, hardness, and appearance met predefined criteria for all batches.
Deviation	One temperature-probe alarm occurred during a controlled hold. Investigation confirmed alarm duration below the validated hold-impact threshold; no CQA impact was found.
Statistics	Within-batch and between-batch variability were consistent with protocol expectations; no adverse trend was observed.
Final recommendation	PPQ successful. Release status is subject to normal batch-release requirements. Continue enhanced CPV for the first defined commercial period and track the preventive action.

Example conclusion: “Based on complete review of the approved protocol, executed manufacturing records, analytical results, process-parameter data, deviation investigation DV-024, and statistical assessment, the three PPQ batches met all predefined acceptance criteria. The evidence demonstrates that the commercial process is capable of reproducible performance and is in a state of control. Enhanced CPV monitoring will continue for the parameters and CQAs identified in the approved monitoring plan.”

PPQ Report Acceptance and Decision Logic

Use a decision tree or structured conclusion so the report does not rely on vague language such as “generally acceptable.” The conclusion should distinguish a successful study from a study that needs additional evidence.

All criteria metConclude successful PPQ when the data, investigations, and approvals support reproducible commercial performance.

Minor exception with no impactDocument scientific rationale, corrective or preventive action, and any enhanced monitoring or restrictions.

Unresolved or material impactDo not claim state of control until investigation, additional testing, repeat qualification, or design work is complete.

Failed PPQDefine the process or product decision, protect affected batches, investigate root cause, and plan additional development or qualification.

The report should state the impact of the decision on batch disposition, commercial distribution, CPV, stability, change control, revalidation, and regulatory commitments.

PPQ Report Approval Checklist

Before approval, Quality should confirm that the report answers the protocol and that the evidence is complete, accurate, and suitable for the final decision.

Protocol number, version, amendments, and executed batch list are correct.
All batch records, samples, laboratory results, and supporting data are reconciled.
Actual process parameters and conditions are compared with approved ranges.
All CQAs, CPPs, IPCs, yields, and release tests are assessed against criteria.
Sampling plan execution and sample representativeness are confirmed.
Statistics match the protocol and assumptions are explained.
Outliers, repeat tests, invalid data, OOS/OOT, and missing results are investigated.
Deviations and nonconformances include impact assessment and status.
Data-integrity and audit-trail checks are documented where applicable.
Limitations and residual risks are stated plainly.
Actions, CAPA, change controls, and CPV commitments have owners and due dates.
Conclusion clearly states pass, conditional acceptance, or additional work required.
Production, QC, Engineering, Validation, QA, Regulatory, and Qualified Person approvals are complete where applicable.
Attachments are legible, controlled, retrievable, and cross-referenced.

Common PPQ Report Failures

Failure pattern	Why it weakens the report	Better practice
Report copies protocol language without actual results.	The reader cannot see what happened or whether criteria were met.	Use planned-versus-actual tables and cross-reference objective evidence.
Only final release results are discussed.	Process variability, in-process controls, and critical trends may be missed.	Include CPPs, IPCs, CQAs, yield, interventions, and time-ordered process data.
Deviations are listed but not assessed.	Impact on product quality and study validity remains unknown.	Summarize root cause, impact, data reviewed, action, and conclusion for each event.
Outliers or repeat tests are silently excluded.	The report may appear selective and undermine data integrity.	Explain all exclusions using approved, scientifically justified procedures.
Statistics are added after seeing results.	Post-hoc analysis may appear designed to obtain a favorable conclusion.	Follow protocol methods or document an approved change and scientific rationale.
Conclusion says “validated” without scope.	It does not clarify which process, batches, conditions, or limitations were demonstrated.	State the exact process, scale, batches, criteria, state of control, and follow-up.
CPV is not connected to PPQ findings.	Important parameters or CQAs may not receive enhanced monitoring after qualification.	Convert PPQ knowledge and residual risks into an approved CPV plan.

PPQ Report and Continued Process Verification

The report should define how PPQ learning transitions into Stage 3 Continued Process Verification. The CPV plan may initially use enhanced sampling and monitoring, then adjust frequency as process knowledge and performance data accumulate.

PPQ output	CPV use
Critical process parameters	Trend routine values, alarms, interventions, and relationships with CQAs.
Critical quality attributes	Monitor batch results, variability, capability, OOS/OOT, complaints, and stability signals.
Residual risk	Set enhanced monitoring, alert/action levels, sampling frequency, and review triggers.
Deviation or CAPA	Verify action effectiveness and check whether recurrence or drift is observed.
Statistical model	Continue run charts, control charts, capability, and trend analysis as justified.

Connect the report to your broader Process Validation in Pharmaceuticals lifecycle and ensure the CPV owner, review frequency, escalation rules, and reporting format are clear.

Related Qualification and Quality-System Evidence

A PPQ report depends on evidence generated before and during manufacturing. Link the report to the applicable qualification, procedure, data-integrity, and quality-event documents.

DQDesign qualification IQInstallation qualification OQOperational qualification PQPerformance qualification URSUser requirements SOPControlled procedures ALCOA+Data integrity 21 CFRRegulatory context

Key Takeaways

A PPQ report is the evidence-based conclusion of Stage 2 process qualification.
Use a controlled format that cross-references the protocol, batches, records, results, deviations, and approvals.
Compare planned versus actual execution and explain batch representativeness.
Summarize within-batch and between-batch variability using protocol-defined statistical methods.
Investigate deviations, OOS/OOT, repeat tests, outliers, missing data, and unexpected observations.
State a clear conclusion about predefined criteria and state of control, including limitations.
Convert PPQ findings into CPV monitoring, CAPA, change control, or additional qualification actions.
Use illustrative templates only as a starting point; product-specific criteria must be approved before execution.

Conclusion

A good PPQ report does more than announce that three batches passed. It shows how the commercial process was executed, how the data were evaluated, how exceptions were investigated, and why the final state-of-control decision is scientifically defensible.

When the report is complete, traceable, data-integrity focused, and approved by accountable functions, it becomes a durable bridge from process qualification to routine manufacturing and CPV. That evidence helps Quality make a clear decision while preserving the knowledge needed for future changes, investigations, inspections, and continual improvement.

Regulatory Reference Points

Use primary guidance and the current applicable GMP requirements when preparing or approving a report:

FDA Process Validation GuidanceGeneral principles and practices EU GMP Annex 15Qualification and validation ICH Q9(R1)Quality risk management cGMPGMP quality foundation

Publishing note: FDA guidance describes recommendations and does not replace applicable statutes, regulations, marketing-authorisation commitments, or approved site procedures. Confirm the current requirements before using a report template for a regulated decision.

Frequently Asked Questions

What is a PPQ report?

A PPQ report is the final controlled document that summarizes execution and results from Process Performance Qualification. It compares actual performance with the approved protocol, evaluates data and deviations, and concludes whether the commercial process is reproducible and in a state of control.

When should a PPQ report be prepared?

Prepare it promptly after the PPQ protocol is completed and the required data, investigations, and laboratory results are available. Delayed reporting can make reconciliation harder and postpone the state-of-control decision.

Is there one mandatory PPQ report format?

No universal template fits every product. The report should be risk-based and include protocol cross-reference, execution, data analysis, deviations, conclusion, actions, approvals, and attachments sufficient to support the decision.

How many batches should a PPQ report cover?

The number of batches is defined in the approved validation strategy and justified by process knowledge, risk, product complexity, commercial scale, and regulatory commitments. The report should state the batch rationale rather than assuming a fixed number.

What is the difference between a PPQ protocol and a PPQ report?

The protocol defines what will be done and the predefined acceptance criteria. The report documents what was actually done, summarizes the results and exceptions, and states the final decision.

What should the executive summary contain?

Include product and protocol identity, batch list, overall criteria status, significant deviations, data limitations, statistical conclusion, state-of-control decision, actions, CPV recommendation, and approval status.

Should deviations be included in the PPQ report?

Yes. Summarize every relevant deviation, atypical result, alarm, intervention, OOS/OOT event, or nonconformance and explain its impact on product quality, data integrity, batch representativeness, and PPQ validity.

Can a PPQ pass if a minor deviation occurred?

It can, if the deviation is investigated under approved procedures, its impact is scientifically assessed, the batch and study remain valid, and Quality approves the documented rationale and any required actions.

What statistics belong in a PPQ report?

Use methods defined in the approved protocol, such as means, ranges, standard deviation, relative standard deviation, confidence intervals, control charts, capability metrics, or other appropriate analyses. Explain assumptions and limitations.

How should outliers be handled?

Investigate the cause and assess the impact using an approved procedure. Do not remove an outlier merely because it weakens the conclusion. Any exclusion must be scientifically justified, documented, and approved.

What does a PPQ report say about state of control?

It should clearly state whether the predefined protocol conditions were met and whether the data support reproducible commercial performance. If not, it should identify what additional work is required before a state-of-control conclusion is made.

What is the role of CPV after PPQ approval?

CPV monitors routine process and product performance after qualification. The PPQ report should identify the parameters, attributes, trends, alert/action levels, frequency, owners, and escalation rules that continue into CPV.

How does ALCOA+ apply to a PPQ report?

ALCOA+ helps confirm that source records and summaries are attributable, legible, contemporaneous, original, accurate, complete, consistent, enduring, and available. The report should retain traceability to the original data.

Who approves a PPQ report?

Approvals depend on the site's quality system, but commonly include Production, Quality Control, Engineering, Validation, Quality Assurance, Regulatory Affairs, and the Qualified Person where applicable.

What happens if PPQ is unsuccessful?

Protect affected batches, document the conclusion, investigate root cause, assess product and regulatory impact, and define additional development, process changes, CAPA, requalification, or repeat PPQ before claiming successful qualification.

Ad Code